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Abstract
Background The aims of this study are the following: to de-
scribe the female population of reproductive age having bar-
iatric surgery in the UK, to assess the age and ethnicity of
women accessing surgery, and to assess the effect of bariatric
surgery on factors that underlie fertility and pregnancy
outcomes.
Methods Demographic details, comorbidities, and operative
type of women aged 18–45 years were extracted from the
National Bariatric Surgery Registry (NBSR). A comparison
was made with non-operative cases (aged 18–45 and BMI
≥40 kg/m2) from the Health Survey for England (HSE,
2007–2013). Analyses were performed using BR^ software.
Results Data were extracted on 15,222 women from NBSR
and 1073 from HSE. Women aged 18–45 comprised 53 % of
operations. Non-Caucasians were under-represented in NBSR
compared to HSE (10 vs 16 % respectively, p < 0.0001). The
NBSR group was older than the HSE group—median 38 (IQR
32–42) vs 36 (IQR 30–41) years (Wilcoxon test p < 0.0001).
Almost one third of women in NBSR had menstrual dysfunc-
tion at baseline (33.0 %). BMI fell in the first year postoper-
atively from 48.2 ± 8.3 to 37.4 ± 7.5 kg/m2 (t test, p < 0.001).
From NBSR, in the postoperative period, the prevalence of
type 2 diabetes fell by 54 %, polycystic ovarian syndrome by
15 %, and any menstrual dysfunction by 12 %.
Conclusions Over half of all bariatric procedures are carried
out on women of reproductive age. More work is required to
provide prompt and equal access across ethnic groups. At least
one in three women suffers from menstrual dysfunction at
baseline. Bariatric surgery improves factors that underlie fer-
tility and pregnancy outcomes. A prospective study is required
to verify these effects.
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Introduction
Obesity and its related comorbidities impair fertility, maternal
health during pregnancy, maternal obstetric outcomes, fetal
outcomes, and long-term health of the offspring [1].
Obesity-related comorbidities are routinely recorded before
and after bariatric surgery in the UK National Bariatric
Surgery Registry (NBSR) [2, 3]. The NBSR is a comprehen-
sive, prospective, nationwide analysis of outcomes from bar-
iatric surgery in the UK and Ireland. The comorbidities mea-
sured include the following: menstrual dysfunction, polycys-
tic ovarian syndrome (PCOS), type 2 diabetes, dyslipidemia,
hypertension, asthma, joint pain, functional status, gastro-
esophageal reflux, and sleep disorder. Menstrual dysfunction,
as defined in the registry, refers to the presence of amenorrhea,
irregular periods, or menorrhagia. Functional status in this
context refers to exercise tolerance, deemed impaired if the
patient is unable to climb a flight of stairs without stopping.
Irregular ovulation associated with menstrual disorders, in-
cluding PCOS, directly affects fertility. Insulin resistance, as a
component of type 2 diabetes, may also affect fertility [4], and,
in addition, the maternal health, fetal outcomes, and long-term
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health of the offspring are impaired by dysglycemia in preg-
nancy [5, 6]. Dyslipidemia is associated with obstetric vascu-
lopathies [7]. Hypertension increases the rates of pre-
eclampsia and small-for-gestational age [8]. Joint pain, func-
tional status, asthma, gastro-esophageal reflux, and sleep dis-
orders are all common in obesity and can all be exacerbated by
pregnancy, impairing the well-being of pregnant women.
Bariatric surgery reduces body weight and is an effective
intervention in treating type 2 diabetes in obese patients [9],
but its effects on fertility and pregnancy outcomes (including
maternal health during pregnancy) are not fully elucidated. It
is known that weight loss achieved through lifestyle change
may help improve fertility [10], but there are limited data
demonstrating that this is the case following BS. The official
NBSR reports demonstrate an improvement in all (ten) record-
ed comorbidities after bariatric surgery, but no subanalyses
have been made in women of reproductive age.
The aims of this study are to describe the cohort of females
of reproductive age having bariatric surgery in the UK, to
assess the age and ethnicity of the cohort who do access sur-
gery, and to assess the effect of bariatric surgery on factors
which underlie fertility and pregnancy outcomes.
Methods
Data were extracted from the UK NBSR for women aged 18–
45 years. Baseline data included age, weight, height, date of
operation, operation type, and presence of comorbidities.
Comparative data from the overall cohort were taken from
the NBSR reports 1 and 2 [2, 3]. Follow-up data were extract-
ed up to 12 months after the operation and included weight
and the presence of comorbidities. The NBSR records ten
comorbidities before and after operation: type 2 diabetes,
menstrual dysfunction, polycystic ovarian syndrome, dyslip-
idemia, hypertension, asthma, joint pain, functional status,
gastro-esophageal reflux, and sleep disorder.
In order to compare the prevalence of each comorbidity
before and after surgery, those patients with missing follow-
up data were initially excluded from analysis. This follows the
convention of the official NBSR reports. Sensitivity analyses
were then applied, assuming that all of the patients with no
follow-up had no change to their status. The prevalences were
compared using the chi-squared test.
For comparison to a representative national cohort, data
were extracted from the Health Survey for England (HSE),
which is an annual national census. Data were collated from
2007 to 2013 inclusive. Women aged 18 to 45 with a BMI
≥40 kg/m2 (representing those who may be considered for
bariatric surgery by NICE criteria) were selected. From this
cohort, the median age was compared to the bariatric surgery
cohort using Wilcoxon’s test. The prevalence of type 2 diabe-
tes and the ethnic composition of the groups were compared
using a chi-squared test. All analyses were performed using
the BR^ statistical software.
Results
NBSR Cohort at the Time of Surgery
In total, there were 29,010 male and female patients who
underwent bariatric surgery to year 2013, of whom 15,222
were women aged 18 to 45 years old (53 %). The numbers
and percentages of each operation, with comparison to the
overall NBSR cohort, are presented in Table 1. The rates of
each operation were no different between the groups. The
discrepancy in the number of BPD procedures is because the
female data dates back to 2003—all 18 of these operations
were performed before 2007.
Comparison of NBSR Patients to HSE Subjects
Collating the HSE data from 2007 to 2013 produced a total
cohort of 91,649 subjects. Female subjects, aged 18–45 years
old, with a recorded BMI of ≥40 kg/m2 totaled 384 subjects.
The NBSR cohort had a median age of 38 years (IQR 32–42)
and was older than the HSE cohort (median 36 years, IQR 30–
41; p < 0.0001, Wilcoxon test). Caucasian patients were over-
represented in the NBSR cohort (90 % of NBSR vs 84 %
HSE, p < 0.0001, chi-squared test, Table 2). Bariatric patients
were twice as likely to have type 2 diabetes as HSE subjects
(14.7 % NBSR vs 7.4 % HSE, p < 0.0001, chi-squared test).
Follow-Up of NBSR Cohort Following Bariatric Surgery
There were 1107 patients with no follow-up data recorded in
the registry, leaving 14,115 women with follow-up data of
some kind. However, there was some inconsistency in record-
ing of comorbidities. For instance, the number of patients with
complete data for hypertension was 8668 (see Table 3). Body
weight and the presence or absence of comorbidities were
recorded at variable time points over the 12-month postoper-
ative period.
The mean BMI fell in the first year postoperatively from
48.2 ± 8.3 to 37.4 ± 7.5 kg/m2 (p < 0.001, t test). As this was
recorded at variable time points, this is represented graphically
(Fig. 1).
Table 3 demonstrates the numbers of each comorbidity at
baseline, following the exclusion of cases with missing data.
Surgery led to a reduction in the numbers of each comorbidity
(Table 4). These findings remained valid after the sensitivity
analysis (i.e., assuming no change in status to patients without
follow-up). Of women with menstrual dysfunction presurgery,
12% of patients normalizedmenstrual function postoperative-
ly. Similarly, of women with PCOS preoperatively, 15 %were
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classed as no longer having the syndrome postoperatively.
Type 2 diabetes showed the greatest improvement with 54 %
of those patients who had diabetes preoperatively achieving a
non-diabetic state postoperatively. The mean total number of
comorbidities per patient fell from 2.36 to 0.96 (p < 0.05,
t test, Fig. 2).
Of those with a single comorbidity preoperatively, func-
tional impairment was the most frequent (46 %). PCOS was
the single comorbidity in only 4 % of these patients and men-
strual dysfunction in 8 %. However, in patients with three
comorbidities, menstrual dysfunction was more commonly
seen: 16 % had PCOS, and 30 % had menstrual dysfunction
(Fig. 3).
Discussion
This study demonstrates that bariatric surgery is effective at
improving factors that may underlie fertility and pregnancy
outcomes: body weight, type 2 diabetes, menstrual dysfunc-
tion, and PCOS. Although baseline numbers may be
questioned in view of missing data, our results demonstrate
improvements in the prevalence of each comorbidity, even
after application of sensitivity analyses.
The meta-analyses have demonstrated that bariatric surgery
improves maternal health during pregnancy (including reduc-
tion in rates of gestational diabetes [11–13] and hypertensive
disorders [11, 13] as well as fetal benefits such as a reduction
in rates of macrosomia [11–13]). Few studies have assessed
the effect of bariatric surgery on menstrual disorders (includ-
ing PCOS), but those available demonstrate excellent results
with 70–80 % achieving normal menstruation postoperatively
[14, 15] although sample sizes are small. Future research
should include a prospective cohort design to investigate
whether the improvements in the comorbidities we have dem-
onstrated also translate to improved fertility.
The dramatic effect onweight is in keeping with data on the
overall bariatric surgery population [2]. A consensus view is
that a reduction in body weight of 10% is a realistic target that
may help improve fertility [16]. Our data show that bariatric
surgery is a very effective means to achieve such a target
(87.3 % of patients achieved ≥10 % weight loss).
Our data gives an intimation of the relative importance to
stakeholders of the comorbidities that lead to a decision for
bariatric surgery. Our data confirm that type 2 diabetes is an
important trigger for bariatric surgery [17] as it was overrep-
resented in the NBSR compared to the HSE cohort. However,
only 3.5 % of patients with a single comorbidity had diabetes,
suggesting that it is not necessarily taken as an indication on
its own. A similar comparison to national data for PCOS and
menstrual dysfunction could not be made as data in the
Table 1 Comparison of the type of operations performed on females of reproductive age versus the total bariatric population
Female, aged 18–45, 2003–2013 NBSR report (financial years ending 2009–2013)
Total Total (%) Lap/endo Open Unspec. Total Total (%) Lap/endo Open Unspec.
Roux-and-Y gastric bypass 8281 54.40 % 7462 811 8 12,759 54.43 % 11,692 1049 18
Gastric band 3955 25.98 % 3941 4 10 5764 24.59 % 5746 9 9
Sleeve gastrectomy 2457 16.14 % 2446 8 3 4174 17.81 % 4140 24 10
Gastric balloon 246 1.62 % 245 0 1 406 1.73 % 402 0 4
Other 126 0.83 % 123 3 0 206 0.88 % 193 8 5
Unspecified 128 0.84 % 8 0 120 116 0.49 % 5 0 111
Biliopancreatic diversion 18a 0.12 % 1 17 0 1a 0.00 % 0 0 1
Duodenal switch 11b 0.07 % 10 1 0 13b 0.06 % 12 1 0
Total 15,222 14,236 844 142 23,439 22,190 1091 158
aNote that the discrepancy between biliopancreatic diversion procedures in the overall NBSR cohort (1) and the selected cohort (18) is because our
search returned all operations recorded on the register. All biliopancreatic diversions recorded in this cohort were performed from 2003 to 2007, whereas
the NBSR formal report is on procedures from 2008
b Four of the DS procedures were performed before 2008
Table 2 Comparison of the ethnic composition of the national obese
population versus the surgical population
Self-reported
ethnicity
UK national population
females aged 18–45 years
old, BMI ≥40 kg/m2
UK females aged 18–45
years old, BMI ≥40 kg/m2,
undergoing bariatric surgery
African/Afro-
Caribbean
7.81 % 4.53 %
Asian 5.73 % 3.54 %
Caucasian 84.1 % 89.9 %
Other 2.34 % 1.99 %
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national HSE cohort were not available for PCOS and men-
strual dysfunction.
Of those with a single comorbidity, PCOS was recorded as
frequently as diabetes (3.8 %) but almost twice as many had a
record of menstrual dysfunction (8 %). Overall, our data dem-
onstrate that PCOS is seen in one in six women having bar-
iatric surgery and menstrual dysfunction is seen in almost one
third of women.
The potential effect of bariatric surgery to improve
fertility, whether as the primary aim of surgery or oth-
erwise, highlights the importance of good preconception
care—which is often suboptimal. In one study, 40 % of
women were not aware of the recommendation to avoid
pregnancy in the first 12–18 months and 30 % did not
use any contraception in the 12 months after operation
[18]. Adherence to these recommendations may be im-
portant to avoid poor neonatal outcomes from macronu-
trient or micronutrient deficiencies [19, 20].
In order to maximize the benefits of bariatric surgery on
fertility and pregnancy outcomes, the potential complications
of surgery must be identified and managed appropriately. A
recent retrospective analysis suggested a possible increase in
neonatal mortality in mothers who underwent bariatric sur-
gery, but this did not control for comorbidities that are likely
to be important confounders [12]. Nevertheless, there may be
an increased risk of preterm delivery [13] and small-for-
gestational-age newborns [11–13] that may be related to the
type of procedure: Biliopancreatic diversion is much more
likely to be associated with small-for-gestational-age neonates
[19], while laparoscopic-assisted gastric bypass does not ap-
pear to increase the rate of small neonates [13]. Note that our
data demonstrate that gastric bypass is the most common op-
eration and that biliopancreatic diversion is rarely performed.
Although included in the NBSR, intragastric balloon insertion
may be considered a bariatric procedure rather than surgery
per se. Our data showed that while these patients have similar
demographics at baseline, the reductions in BMI were less
(49.8 ± 18.1 to 45.7 ± 15.0 kg/m2) and improvements in the
comorbidities were not seen. Indeed, the rates of different
operations in female patients of childbearing age closely
match those in the total NBSR cohort (Table 1). The similar
rates for each operation raise the issue of whether this is ap-
propriate or whether different operations should be offered to
these women.
Open and timely access to bariatric surgery is important to
optimize its benefits. Our data demonstrate that ethnic minor-
ities are under-represented in the operated population, sug-
gesting reduced access. This will require further investigation
to explain possible cultural barriers and to prevent health in-
equalities in access to services.
Table 3 The rate of obesity-
related comorbidities at baseline Comorbidity Number of cases Total number of patients (with complete data) Prevalence
Menstrual dysfunction 2355 7134 33.0 %
PCOS 1298 8250 15.7 %
Type 2 diabetes 1266 8609 14.7 %
Dyslipidemia 970 8558 11.3 %
Hypertension 1736 8623 20.1 %
Sleep disorder 985 8201 12.0 %
Impaired functional status 5607 8394 66.8 %
Joint pain 3707 8528 43.5 %
Asthma 1742 8623 20.2 %
Gastro-esophageal reflux 1560 7415 21.0 %
Fig. 1 Change in BMI based on
themonth of follow-up. Themean
BMI at baseline is shown by dot
and error bars at 0 months. The
mean BMI recorded at each
month of follow-up with error
bars. One point per patient is
shown on graph
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The operated cohort was older than the eligible population
of age-matched women. One interpretation for this is that
there is a lead time from patients being eligible for surgery
to having the operation. This delay is important as it falls
around the key age for pregnancy success with a diminishing
ovarian reserve. It has been demonstrated that before the age
of 37, obesity has a significant negative impact on fertility,
whereas in older women, this effect is outweighed by advanc-
ing age [21]. Thus, weight loss to improve fertility should
ideally occur before this age [22]. That such a delay is hap-
pening may be due to delays in identification of eligible pa-
tients, delays in referral, and waiting lists for the operation
itself. Clinicians should consider the benefits of operating ear-
lier in young obese women, especially if fertility is a major
concern.
The limitations of this study stem from limitations of the
registry itself. Further information on preoperative childbear-
ing history, parous state, and postoperative pregnancy would
allowmore direct conclusions to be drawn about the effects on
fertility and pregnancy. Other data surrounding preconception
care such as postoperative micronutrient supplementation or
deficiency, contraceptive use, and hormonal supplementation
are not recorded. It should also be noted that there is no site
visit for the verification of the reported data. In the NBSR, the
data is self-reported by each surgeon.
In summary, over half of all bariatric procedures are carried
out on women of reproductive age. At least one in three of
these women havemenstrual dysfunction at baseline. Bariatric
surgery improves factors that underlie fertility and pregnancy
outcomes. A prospective study is required to demonstrate that
this effect translates into a positive effect on pregnancy
outcomes.
Table 4 Improvement in the rate of obesity-related comorbidities after
operation
Comorbidity Number of
patients with
comorbidity
before surgery
Number of
patients with
comorbidity
after surgery
Proportion
improved
after surgery
p value
Menstrual
dysfunction
2355 2063 12.4 % p<0.0001
PCOS 1298 1106 14.8 % p<0.0001
Type 2 diabetes 1266 587 53.6 % p<0.0001
Dyslipidemia 970 497 48.8 % p<0.0001
Hypertension 1736 1013 41.7 % p<0.0001
Sleep disorder 985 561 43.1 % p<0.0001
Impaired
functional
status
5607 2967 47.1 % p<0.0001
Joint pain 3707 2605 29.7 % p<0.0001
Asthma 1742 1222 29.9 % p<0.0001
Gastro-esophageal
reflux
1560 1312 15.9 % p<0.0001
Fig. 2 Total number of comorbidities before and after operation
Fig. 3 Relative contribution of each comorbidity before and after
operation
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